Daily Archives: February 8, 2020

Takeda

CAR natural killer cell therapy – MD Anderson partners with Takeda

February 8th, 2020 CAR NK-Cell therapy, Immunotherapy, Leukemia

The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited have entered a restrictive understanding and research consent to develop and market chimeric antigen receptor directed natural killer (CAR NK)- cell trea.... Read More

CAR-NK therapy – New immunotherapy in cancer treatment

February 8th, 2020 CAR NK-Cell therapy, Immunotherapy, Leukemia

CAR-NK therapy is a new type of immunotherapy in the treatment of cancer treatment. Immunotherapy has revolutionized the way cancer is treated. Cancer immunotherapy is divided into two categories: one is immune checkpoint inhibitors, and PD-1, .... Read More